Han KH - Search Results

1

A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements.

Kudo M, Han KH, Ye SL, Zhou J, Huang YH, Lin SM, Wang CK, Ikeda M, Chan SL, Choo SP, Miyayama S, Cheng AL. Kudo M, et al. Among authors: han kh. Liver Cancer. 2020 Jun;9(3):245-260. doi: 10.1159/000507370. Epub 2020 May 13. Liver Cancer. 2020. PMID: 32647629 Free PMC article.

2

Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma.

Park JY, Ahn SH, Yoon YJ, Kim JK, Lee HW, Lee DY, Chon CY, Moon YM, Han KH. Park JY, et al. Among authors: han kh. Cancer. 2007 Jul 1;110(1):129-37. doi: 10.1002/cncr.22759. Cancer. 2007. PMID: 17508408 Free article. Clinical Trial.

3

Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis.

Han KH, Seong J, Kim JK, Ahn SH, Lee DY, Chon CY. Han KH, et al. Cancer. 2008 Sep 1;113(5):995-1003. doi: 10.1002/cncr.23684. Cancer. 2008. PMID: 18615601 Free article. Clinical Trial.

4

Epidemiology of hepatocellular carcinoma in Japan and Korea. A review.

Kim SR, Kudo M, Hino O, Han KH, Chung YH, Lee HS; Organizing Committee of Japan-Korea Liver Symposium. Kim SR, et al. Among authors: han kh. Oncology. 2008;75 Suppl 1:13-6. doi: 10.1159/000173419. Epub 2008 Dec 17. Oncology. 2008. PMID: 19092267

5

Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinion.

Chen PJ, Furuse J, Han KH, Hsu C, Lim HY, Moon H, Qin S, Ye SL, Yeoh EM, Yeo W. Chen PJ, et al. Among authors: han kh. Liver Int. 2010 Nov;30(10):1427-38. doi: 10.1111/j.1478-3231.2010.02292.x. Liver Int. 2010. PMID: 20557456 Review.

6

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Omata M, et al. Among authors: han kh. Hepatol Int. 2010 Mar 18;4(2):439-74. doi: 10.1007/s12072-010-9165-7. Hepatol Int. 2010. PMID: 20827404 Free PMC article.

7

Liver Cancer Working Group report.

Kudo M, Han KH, Kokudo N, Cheng AL, Choi BI, Furuse J, Izumi N, Park JW, Poon RT, Sakamoto M. Kudo M, et al. Among authors: han kh. Jpn J Clin Oncol. 2010 Sep;40 Suppl 1:i19-27. doi: 10.1093/jjco/hyq123. Jpn J Clin Oncol. 2010. PMID: 20870915

8

Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma.

Yeo W, Chen PJ, Furuse J, Han KH, Hsu C, Lim HY, Moon H, Qin S, Yeoh EM, Ye SL. Yeo W, et al. Among authors: han kh. BMC Cancer. 2010 Nov 10;10:620. doi: 10.1186/1471-2407-10-620. BMC Cancer. 2010. PMID: 21062497 Free PMC article.

9

18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.

Kim BK, Kang WJ, Kim JK, Seong J, Park JY, Kim DY, Ahn SH, Lee DY, Lee KH, Lee JD, Han KH. Kim BK, et al. Among authors: han kh. Cancer. 2011 Oct 15;117(20):4779-87. doi: 10.1002/cncr.26099. Epub 2011 Apr 5. Cancer. 2011. PMID: 21469082 Free article.

10

Treatment of recurrent hepatocellular carcinoma after liver transplantation.

Kim HR, Cheon SH, Rha SY, Lee S, Han KH, Chon CY, Lee JD, Sung JS, Chung HC. Kim HR, et al. Among authors: han kh. Asia Pac J Clin Oncol. 2011 Sep;7(3):258-69. doi: 10.1111/j.1743-7563.2011.01425.x. Asia Pac J Clin Oncol. 2011. PMID: 21884437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,585 results

Search Page